20 March 2026 08:03

Although the global market remained weak during the year, 2025 marked a breakthrough in the areas that are most important to Cell Impact. Cost control, project deliveries and deeper partner and customer relationships strengthened the company’s position.

In 2025, Cell Impact continued to lay the foundations for the company’s survival and to strengthen its market position.

“In the fourth quarter of 2025, we announced a strategic cooperation agreement with thyssenkrupp Automation Engineering, one of Europe’s leading industrial players in advanced automation equipment. In 2025, we also refined and expanded our core operations by introducing Cell Impact Cutting, which is based on our patented forming technology. This will allow us to cost-effectively cut high-quality metal rods at a high frequency, for example, opening the door to completely new market segments,” says Daniel Vallin, CEO of Cell Impact.

Cell Impact started 2026 by completing the rights issue presented in December 2025. In February, Cell Impact announced a renewed agreement, strengthening the company’s cash position by SEK 6 million.

“These two pieces of good news, together with the capital injection from the rights issue, mean that we have a stronger financial position than we could have hoped for in December 2025. We are now continuing to focus on business that will generate increased sales and positive cash flow in 2026,” Daniel Vallin concludes.

For more information, please contact:
Daniel Vallin
CEO and IR contact, Cell Impact AB
+46 730686620 or daniel.vallin@cellimpact.com

About Cell Impact
Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell and electrolyzer manufacturers. The company has developed and patented a unique method for high velocity forming, Cell Impact Forming™ which is significantly more scalable and cost-efficient compared to conventional forming methods. Cell Impact Forming is an environmentally friendly forming technology that consumes no water and very little electrical power. The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company’s Certified Advisor (CA).